Author Correction: A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors.


Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
Aug 2020
Historique:
pubmed: 27 6 2020
medline: 27 6 2020
entrez: 27 6 2020
Statut: ppublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

pubmed: 32587393
doi: 10.1038/s41591-020-0976-3
pii: 10.1038/s41591-020-0976-3
pmc: PMC7417328
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

1307

Subventions

Organisme : NCI NIH HHS
ID : HHSN261201500003C
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261201500003I
Pays : United States
Organisme : NCI NIH HHS
ID : K08 CA237871
Pays : United States

Commentaires et corrections

Type : ErratumFor

Auteurs

Michal Slyper (M)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Caroline B M Porter (CBM)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Orr Ashenberg (O)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Julia Waldman (J)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Eugene Drokhlyansky (E)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Isaac Wakiro (I)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA.

Christopher Smillie (C)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Gabriela Smith-Rosario (G)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Jingyi Wu (J)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA.

Danielle Dionne (D)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Sébastien Vigneau (S)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA.

Judit Jané-Valbuena (J)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Timothy L Tickle (TL)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Sara Napolitano (S)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA.

Mei-Ju Su (MJ)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA.

Anand G Patel (AG)

Department of Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, TN, USA.
Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, USA.

Asa Karlstrom (A)

Department of Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, TN, USA.

Simon Gritsch (S)

Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Masashi Nomura (M)

Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Avinash Waghray (A)

Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA.

Satyen H Gohil (SH)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Alexander M Tsankov (AM)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Livnat Jerby-Arnon (L)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Ofir Cohen (O)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA.

Johanna Klughammer (J)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Yanay Rosen (Y)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Joshua Gould (J)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Lan Nguyen (L)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Matan Hofree (M)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Peter J Tramontozzi (PJ)

Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA, USA.

Bo Li (B)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Catherine J Wu (CJ)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Department of Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Benjamin Izar (B)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA.
Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA.
Center for Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.
Ludwig Center for Cancer Research at Harvard, Boston, MA, USA.
Melanoma Disease Center, Dana-Farber Cancer Institute, Boston, MA, USA.
Columbia Center for Translational Immunology and Division of Hematology and Oncology, Columbia University Medical Center, New York, NY, USA.

Rizwan Haq (R)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

F Stephen Hodi (FS)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Melanoma Disease Center, Dana-Farber Cancer Institute, Boston, MA, USA.

Charles H Yoon (CH)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Department of Surgical Oncology, Brigham and Women's Hospital, Boston, MA, USA.

Aaron N Hata (AN)

Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Suzanne J Baker (SJ)

Department of Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, TN, USA.

Mario L Suvà (ML)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Raphael Bueno (R)

Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA, USA.

Elizabeth H Stover (EH)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Michael R Clay (MR)

Department of Pathology, St Jude Children's Research Hospital, Memphis, TN, USA.

Michael A Dyer (MA)

Department of Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, TN, USA.
Howard Hughes Medical Institute, Chevy Chase, MD, USA.

Natalie B Collins (NB)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Division of Pediatric Hematology and Oncology, Boston Children's Hospital, Boston, MA, USA.

Ursula A Matulonis (UA)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Nikhil Wagle (N)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA.
Department of Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Bruce E Johnson (BE)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA.

Asaf Rotem (A)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA.

Orit Rozenblatt-Rosen (O)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA. orit@broadinstitute.org.

Aviv Regev (A)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA. aregev@broadinstitute.org.
Howard Hughes Medical Institute, Chevy Chase, MD, USA. aregev@broadinstitute.org.
Koch Institute for Integrative Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA. aregev@broadinstitute.org.

Classifications MeSH